<DOC>
	<DOCNO>NCT00581763</DOCNO>
	<brief_summary>This study people certain type protein blood , call anti-phospholipid antibody . The presence antibody associate complication ( e.g . blood clot ) know change time . The purpose study evaluate change improve ability determine long-term outcome affected individual .</brief_summary>
	<brief_title>Long-Term Outcome Children Adolescents With Anti-Phospholipid Antibodies</brief_title>
	<detailed_description>Aim : 1 . Determine incidence , time frame , aquiring aPL cohort aPL-negative pediatric SLE subject . 2 . Determine incidence , time frame , develop first APS-associated complication among SLE subject detectable aPL . 3 . Determine incidence , time frame , develop second APS-associated event among subject history APS-associated event . 4 . Determine incidence , time frame , develop SLE among subject history APS-associated event absence SLE . 5 . Identify laboratory clinical predictor event describe aims 1-4.Research Design Methods : This prospective cohort study determine risk develop aPL APS-related symptom young group SLE APS subject . Patients follow ten year period undergo annual serologic clinical evaluation identify disease progression .</detailed_description>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Antiphospholipid</mesh_term>
	<criteria>Age : Less 21 year baseline exam Diagnosis : patient must meet criterion one five diagnostic category base classification accord three parameter ; aPL positivity , APS criterion , SLE criterion . The five diagnostic category : SLE aPL SLE aPL , without manifestation APS SLElike APS SLE APS Primary APS .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>